simvastatin/ezetimibe	placebo	low-density lipoprotein cholesterol	732	895	Simvastatin/ezetimibe reduced low-density lipoprotein cholesterol (3.49 (2.94 to 4.15) to 1.32 (1.02 to 1.69) vs 3.46 (2.92 to 4.08) to 3.34 (2.81 to 3.92) mmol/L)
simvastatin/ezetimibe	placebo	hsCRP	732	1039	Simvastatin/ezetimibe reduced low-density lipoprotein cholesterol (3.49 (2.94 to 4.15) to 1.32 (1.02 to 1.69) vs 3.46 (2.92 to 4.08) to 3.34 (2.81 to 3.92) mmol/L) and hsCRP (2.1 (0.9 to 4.1) to 1.2 (0.6 to 2.4) vs 2.2 (0.9 to 4.9) to 1.8 (0.85 to 4.35) mg/L, all p<0.05) during the first year of treatment.
simvastatin/ezetimibe	placebo	hsCRP	-1	-1	Variable <TAB> Allocation <TAB> Baseline <TAB> Year 1 <TAB> Paired p value <TAB> One-year changeshsCRP (mg/L) <TAB> Treatment <TAB> 2.1 (0.9–4.1)* <TAB> 1.2 (0.6–2.4)* <TAB> <0.001 <TAB> 1.76 (0.0–4.4)**Placebo <TAB> 2.2 (0.9–4.9) <TAB> 1.8 (0.85–4.35) <TAB> 0.003 <TAB> 0.00 (−1.5–2.1)
